Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
Andrew Nunn, Professor of Epidemiology, Medical Research Council Clinical Trials Unit at UCL, describes the first phase 3 trial of a shortened treatment for MDR-TB.
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders